Engages Top International Nanotechnology Expert to serve as Scientific Advisor for the Sencell Development

January 20, 2020

Lifecare AS is pleased to welcome Prof. Michael Huth, Professor for Thinlayer Physics at the Johann-Wolfgang-vom-Goethe University in Frankfurt and one of the Global International Leaders in the field of Nanosensing Technology as a new member of the Scientific Advisory Board for the Sencell Development.

Lifecare AS is pleased to welcome Prof. Michael Huth, Professor for Thinlayer Physics at the Johann-Wolfgang-vom-Goethe University in Frankfurt and one of the Global International Leaders in the field of Nanosensing Technology as a new member of the Scientific Advisory Board for the Sencell Development.

"Prof. Huth is an outstanding scientist and will bring extremely valuable support to the existing advisory board, which is already composed of leading international experts in the field of diabetes and diabetes technology" says Prof. Andreas Pfützner, Chief Scientific Officer of Lifecare and Christian Torp Saure, Lifecare's Executive Chairman, adds: "Having Prof. Huth join our advisory board is not only a major achievement in the atempt to finalize the Sencell development, but also a further proof for the acceptance by the scientific community of Lifecare's Sencell development and for the companies' vision to help people suffering from diabetes."

In addition to Prof Huth the Lifecare AS' Scientific Advisory Board includes:

Chairman: Prof. David C. Klonoff

  • Clinical Professor of Medicine, University of California San Francisco
  • Medical Director of the Dorothy L. and James E. Frank Diabetes Research
  • Medical Director of the Dorothy L. and James E. Frank Diabetes Research
  • Editor in Chief, Journal of Diabetes Science and Technology

Member: Prof. Lutz Heinemann

  • Founding partner, Profil Institute for Metabolic Research in Neuss, Germany
  • Member of the German Diabetes Association (DDG), the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA)
  • Co-Editor, Journal of Diabetes Science and Technology
  • Awarded for “Leadership in Diabetes Technology” and “Artificial Pancreas
  • Research Award” from the Diabetes Technology Society

Member: CMO: Prof. Kåre Birkeland

  • Professor of Internal Medicine and Endocrinology, University of Oslo
  • Senior consultant in Endocrinology, Dep. of Transplantation Medicine, Rikshospitalet, Oslo University Hospital
  • Chairman Advisory Board, Norwegian Diabetes Association